Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-10-11
1996-12-17
Rotman, Alan L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546242, 546244, 546247, 546132, 546209, 548531, 548537, 548557, C07D20710, C07D20714, C07D21134, C07D21162
Patent
active
055854923
ABSTRACT:
The present invention provides compounds of the formula Ar.sup.1 --Q--Ar.sup.2 --Y--R--Z and pharmaceutically acceptable salts thereof wherein Ar.sup.1 and Ar.sup.2 are optionally substituted aryl moieties, Z is an optionally substituted nitrogen-containing moiety which may be an acyclic, cyclic or bicyclic amine or an optionally substituted monocyclic or bicyclic nitrogen-containing heteroaromatic moiety; Q is a linking group capable of linking two aryl groups; R is an alkylene moiety; Y is a linking moiety capable of linking an aryl group to an alkylene moiety and wherein Z is bonded to R through a nitrogen atom. The compounds and pharmaceutical compositions of the present invention are useful in the treatment of inflammatory diseases which are mediated by LTB.sub.4 production, such as psoriasis, ulcerative colitis, IBD and asthma.
REFERENCES:
patent: 2831859 (1958-04-01), Kindler et al.
patent: 4010272 (1977-03-01), Loewe et all
patent: 4038319 (1977-07-01), Pinhas
patent: 4339576 (1982-07-01), Zenitz
patent: 4417052 (1983-11-01), Zenitz
patent: 4803227 (1989-02-01), Brandes et al.
patent: 4829068 (1989-05-01), Brandes et al.
L. Brades et al. Chem. Abstr. 115:64790h, "Treatment of ulcer disorders of the gastrointestinal tract with diphenylmethane derivatives" (1991).
A. Fargin et al. Chem.-Biol. Interactions, 66, 101-109 (1988), "Further Evidence For a Biological Role of Anti-Estrogen-Binding Sites in Mediating the Growth Inhibitory Action of Diphenylmethane Derivatives".
K. Kindler et al. Ann die Chemie (617), 25-54 (1958), "Katalytisch-Specifische Kondensationen mit Dihalogeniden, I".
R. Labaudini ere et al. J. Med. Chem., 35, 3170-3179 (1992), ".omega.-[(.omega.-Arylalkyl)thienyl]alkanoic Acids: From Specific LTA.sub.4 Hydrolase Inhibitors to LTB.sub.4 Receptor Antagonists".
R. Labaudini ere et al. J. Med. Chem., 35, 3156-3169 (1992), ".omega.-[(.omega.-Arylalkyl)aryl]alkanoic Acids: A New Class of Specific LTA.sub.4 Hydrolase Inbitors".
F. Lakhdar-Ghazal et al. Biochemical Pharmacology42(11), 2099-2105 (1991), "Interactions Between Trypanocidal Drugs and Membrane Phospholipids".
D. Nardi et al. II Farmaco-Ed. Sc..--vol. 20(8) 557-565 (1965), "Nuovi Sali Ammonici Quaternari Ad Attivita Ganglioplegica E. Ipotensiva".
A. Oda et al. Chem. Abstr. 119:88896f, "Phenoxyethylamines as bactericides for crops" (1993).
M. Protiva et al. Chem. listech 43, 254-257 (1949) "Antihistaminov e l atky XIV.*) Basick e ethery odvozen e od 2-a 4-hydroxydifenylsulfidu, 2-hydroxydifenyletheru a 2-hydroxydifenylaminu".
W. Yuan et al. J. Med. Chem., 36, 211-220 (1993), "Development of Selective Tight-Binding Inhibitors of Leukotriene A.sub.4 Hydrolase".
W. Yuan et al. J. Am. Chem. Soc. 114, 6552-6553 (1992), "Novel Tight-Binding Inhibitors of Leukotriene A.sub.4 Hydrolase".
Chandrakumar Nizal S.
Chen Barbara B.
Clare Michael
Desai Bipinchandra N.
Djuric Stevan W.
G. D. Searle & Co.
Rotman Alan L.
LandOfFree
LTA.sub.4 Hydrolase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with LTA.sub.4 Hydrolase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LTA.sub.4 Hydrolase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1992407